Skip to main content
Claudio Brunstein, MD, Hematology, Cleveland, OH

Claudio Garcia Brunstein MD PhD (He/Him)

Hematologic Oncology


Cleveland Clinic Foundation, Cleveland, OH

Join to View Full Profile
  • 10201 Carnegie AveCA-60Cleveland, OH 44195

Dr. Brunstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1998 - 2002
  • Federal University of Rio Grande do Sul School of Medicine
    Federal University of Rio Grande do Sul School of MedicineClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2022 - 2026
  • MN State Medical License
    MN State Medical License 2002 - 2022
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment Kinetics  
    Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica

Abstracts/Posters

  • Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...
    Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
    Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...
    Claudio G. Brunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Validation of Minnesota Acute Gvhd Risk Score and Identification of New Factors Associated with Initial Response to Steroids: Not All Gvhd Is Created Equal 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood Cancer
    University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 23rd, 2019
  • First-Ever US Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood Cancer
    First-Ever US Clinical Trial of Engineered iPSC-Derived Cell Therapy for Blood CancerOctober 21st, 2019
  • Half-Matched Transplants Widen Pool of Donors for Leukemia and Lymphoma
    Half-Matched Transplants Widen Pool of Donors for Leukemia and LymphomaJuly 8th, 2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: